FHI 360 Vietnam is currently seeking a high qualified clinical research organization (CRO) to support operations and data-collection for a Non-Inferiority Assessment to compare Dolutegravir-based (Acriptega) Antiretroviral Therapy (ART) Viral Suppression and Acceptability to Efavirenz-based ART in Vietnam. The assessment is funded by USAID under the contract #AID-440-C-16-00001 “Sustainable HIV and Tuberculosis Response From Technical Assistance (SHIFT) Project” and cooperative agreement #7200AA19CA00002 “Meeting Targets and Maintaining Epidemic Control (EpiC) Project”.

Attachments:

• Request for proposals
• Attachment A - Budget Template
• Attachment B - Biodata

Interested entity should submit Complete Proposals via email to [email protected] with a copy to [email protected] no later than 5:00 pm Hanoi on July 28, 2020.

Organization: FHI 360
Location:
Application deadline: 2020-07-28
Send application to: [email protected]; [email protected]